Pages that link to "Q72707580"
Jump to navigation
Jump to search
The following pages link to Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats (Q72707580):
Displaying 50 items.
- GDNF is not required for catecholaminergic neuron survival in vivo (Q27312615) (← links)
- Striatal glutamate release in L-DOPA-induced dyskinetic animals (Q28485942) (← links)
- Dopamine neuron stimulating actions of a GDNF propeptide (Q28748465) (← links)
- Manipulation of Rat Movement via Nigrostriatal Stimulation Controlled by Human Visually Evoked Potentials (Q30853235) (← links)
- Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models (Q30912095) (← links)
- Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats (Q31872260) (← links)
- Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. (Q31923931) (← links)
- Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation (Q33520922) (← links)
- Differential Proteome of the Striatum from Hemiparkinsonian Rats Displays Vivid Structural Remodeling Processes (Q33643389) (← links)
- Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats (Q33822306) (← links)
- Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease (Q33939090) (← links)
- Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. (Q34120733) (← links)
- Evidence of d-phenylglycine as delivering tool for improving l-dopa absorption (Q34137524) (← links)
- Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion (Q34173113) (← links)
- Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer (Q34285849) (← links)
- Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle (Q34328723) (← links)
- Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins (Q34330389) (← links)
- Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease (Q34435195) (← links)
- Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake (Q34540567) (← links)
- Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia (Q35038040) (← links)
- Monoamine reuptake inhibitors in Parkinson's disease (Q35165280) (← links)
- Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion (Q35190293) (← links)
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. (Q35589979) (← links)
- Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. (Q35734505) (← links)
- Cell-based therapies for Parkinson disease—past insights and future potential (Q35736662) (← links)
- Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease (Q35847142) (← links)
- Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway (Q35957491) (← links)
- Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. (Q36561684) (← links)
- A homeodomain gene Ptx 3 has highly restricted brain expression in mesencephalic dopaminergic neurons (Q36725828) (← links)
- The 6-hydroxydopamine model of Parkinson's disease (Q36797981) (← links)
- Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease. (Q36930483) (← links)
- Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease (Q37151436) (← links)
- Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease (Q38542752) (← links)
- ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion (Q38932223) (← links)
- Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats (Q39427473) (← links)
- The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model (Q39668035) (← links)
- Uptake of 6‐[18F]fluoro‐L‐dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease (Q39669275) (← links)
- Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test (Q39696572) (← links)
- Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states (Q39996419) (← links)
- Quantitative video-based gait pattern analysis for hemiparkinsonian rats (Q40042172) (← links)
- Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement. (Q40045483) (← links)
- Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats (Q40160184) (← links)
- Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. (Q40216832) (← links)
- Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats. (Q40225003) (← links)
- Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease (Q40633580) (← links)
- Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease (Q40737427) (← links)
- The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages (Q40885905) (← links)
- GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys (Q40980563) (← links)
- 6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor (Q41170164) (← links)
- Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. (Q41345669) (← links)